CD158a (KIR2DL1) Antibody, anti-human, APC, REAfinity™ 130-120-584 from Miltenyi Biotec

Product Specs
ItemCD158a (KIR2DL1) Antibody, anti-human, APC, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-120-584
Quantity30 tests in 60 µL
ApplicationsFlow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry, Immunocytochemistry
Concentration1:50
Conjugate/TagAPC
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivityhuman
IsotypeIgG1
ModificationsRecombinantly engineered
CloneREA284
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
NCBI Full Gene Namekiller cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1
NCBI Gene AliasesCD158A, KIR-K64, KIR221, KIR2DL3, NKAT, NKAT-1, NKAT1, p58.1
Clonalitymonoclonal
TargetCD158a (KIR2DL1)
Research AreaFor research use only
Regulatory StatusFor research use only

Local Office

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

International Office

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

(1) Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR ProfilesFrontiers in ImmunologyOctober 15, 2020Benjamin H. Goldenson et al.clone GL183), CD158e1(KIR3DL1)-BV421 (BioLegend, 312713, clone DX9), CD158a(KIR2DL1)-APC (Miltenyi, 130-120584, clone REA284), CD158b1/b2,j (KIR2DL2, KIR2DL3, KIR2DS2)-PE-Cy5.5 (Beckman Coulter, A66900, clone GL183), CD158a,h(KIR2DL,

(2) Peptide-specific engagement of the activating NK cell receptor KIR2DS1Scientific reportsMay 25, 2017Chapel A, Garcia-Beltran WF, Hölzemer A, Ziegler M, Lunemann S, Martrus G, Altfeld M.

(4) Suppression of HIV Replication by CD8(+) Regulatory T-Cells in Elite ControllersFrontiers in immunologyJanuary 1, 2016Lu W, Chen S, Lai C, Lai M, Fang H, Dao H, Kang J, Fan J, Guo W, Fu L, et al.

(6) Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptorsImmunitySeptember 1, 1998Valés-Gómez M, Reyburn HT, Mandelboim M, Strominger JL.

CD158a (KIR2DL1) Antibody, anti-human, APC, REAfinity™ from Miltenyi Biotec